Definitive Contract N6833525C0285
Award Date 9/30/25
Potential Completion Date 10/1/29
Potential Value $2M
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
Total Small Business
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Lowell, MA 01852, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
10
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
STTR Phase II
Primary Consortia Member
Not listed Similar Awards
- This is a Small Business Technology Transfer (STTR) Phase I contract awarded by the Office of Naval Research (ONR) to Emergingdx Inc., a small business subchapter S corporation based in Mansfield, Massachusetts. The $246,350.00 firm fixed-price contract supports the development of an advanced diagnostic and biosensor technology platform for medical research and precision medicine applications, with a focus on disease detection, biomarker analysis, and rapid diagnostic solutions. The contract...
- This is a firm fixed price SBIR Phase I contract awarded by the Department of the Navy Secretary of the Navy Office of Naval Research to Emergingdx Inc., a for-profit subchapter S corporation. The $239,636.00 contract funds research under the SBIR Program to advance disease detection and precision medicine capabilities. Emergingdx Inc. has also received several other recent SBIR and STTR Phase I awards from the Defense Health Agency and Department of Agriculture to develop biosensors, microRNA...
- The Defense Health Agency awarded a Phase II Small Business Innovation Research (SBIR) contract valued at approximately $1.3 million to Emergingdx Inc., a Lowell, Massachusetts-based diagnostic technology company. This total small business set-aside contract, designated as a Definitive Contract with firm fixed pricing, supports the development of a rapid, automated, multiplexed omics platform. The contract was awarded on September 26, 2025, with an ultimate completion date of January 25, 2028....
- This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Health Agency (DHA) to Emergingdx Inc., a small business based in Mansfield, Massachusetts. The contract, valued at $1,299,988.98, supports the development of an automated detection platform for circulating and exosomal microRNAs. This research and development effort is focused on medical diagnostics and aligns with the DHA's mission to advance healthcare technologies. The contract was awarded on...
- Emergingdx Inc. was awarded a $249,837 firm fixed price Small Business Technology Transfer (STTR) Phase I contract by the Defense Health Agency (DHA) to develop a multiplexed biosensor for rapid detection of a multi-omics biomarker panel. The research will be conducted over a seven-month period ending in May 2024 at Emergingdx's facility in Mansfield, Massachusetts. The contract has a total small business set aside designation. The DHA oversees medical research and development programs within...
- The U.S. Defense Health Agency (DHA) awarded a Small Business Technology Transfer (STTR) Phase II contract to Emergingdx Inc., a small business subchapter S corporation based in Lowell, Massachusetts. The $1,299,985.23 Firm Fixed Price contract, which is set aside for total small business, supports the development of a "Multiplexed Diagnostic Platform for Invasive Fungal Infection." This contract builds upon earlier SBIR Phase I exploratory research and aims to advance innovative...
- This federal contract award is for a Small Business Innovation Research (SBIR) Phase I project from the Defense Health Agency (DHA) to Emergingdx Inc., a small business subchapter S corporation based in Mansfield, Massachusetts. The contract, valued at $249,993.61, supports the development of a "Rapid, Automated, Multiplexed Omics Platform" for medical research and diagnostic applications. As a total small business set-aside contract, this award demonstrates Emergingdx Inc.'s expertise...
- The Defense Health Agency (DHA) awarded a $249,837.63 Small Business Technology Transfer (STTR) Phase I contract to Emergingdx Inc., a small business subchapter S corporation based in Mansfield, Massachusetts. The contract is for the development of an automated detection platform for circulating and exosomal microRNAs, with potential applications in early disease detection and precision medicine. This contract is part of the DHA's research and development efforts in advanced diagnostic and...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Health Agency (DHA) to Emergingdx Inc., a for-profit subchapter S corporation based in Mansfield, Massachusetts. The $249,998.68 firm-fixed-price contract is for the development of a "Multiplexed Diagnostic Platform for Invasive Fungal Infection." Emergingdx is a company focused on developing diagnostic and biosensor technologies, with an emphasis on disease detection and precision medicine...
- Exodigm Biosciences, Inc. has been awarded a $2.34 million firm fixed-price definitive contract by the Naval Information Warfare Systems Command (NIFC) for the development of transmembrane nano sensors designed for live cell genotyping and enrichment applications. The contract, awarded on May 3, 2023, represents final funding for Milestone 1001AG and carries a completion deadline of May 21, 2025. Performance will be conducted at the contractor's facility in Menlo Park, California. This...